Why are Trump’s new tariffs targeting EU and Mexico?
How did Bitcoin reach a record high again?
Why is Meta investing billions in AI infrastructure?
What caused Tesla’s Autopilot legal trial in Florida?
How will Walmart's water bottle recall impact sales?
Why is Starbucks mandating office return four days weekly?
What effect will Trump’s Patriot missile plan have on Ukraine?
Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery
benzinga.com/news/health-care/25/07/46401053/amylyxs-avexitide-patients-weight-loss-surgery
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) on Sunday presented new exploratory analyses from its Phase 2 PREVENT and Phase 2b trials of avexitide—an investigational GLP-1 receptor antagonist—at the Endocrine Society's annual meeting (ENDO 2025).
The drug targets post-bariatric…
This story appeared on benzinga.com, 2025-07-14 18:15:11.